Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors

Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors

US Patent 9856234 · Granted Jan 2, 2018

Estimated economic value: $106,945,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocyclic compounds as S1P modulators2020
Tricyclic compounds2019
Tricyclic quinoline and quinoxaline derivatives2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Tricyclic quinoline and quinoxaline derivatives2018
Modulators of 5-HT receptors and methods of use thereof2018
Inhibitor compounds of phosphodiesterase type 10A2017
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazin2017
Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modu2017
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2017
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2017